Notice of NIDCR's Participation in PAR-19-193 "Microbial-based Cancer Therapy-Bugs as Drugs (R01- Clinical Trial Not Allowed)"

Notice Number: NOT-DE-19-006

Key Dates
Release Date: April 25, 2019

Related Announcements
PAR-19-193

Issued by
National Institute of Dental and Craniofacial Research (NIDCR)

Purpose

This notice informs potential applicants that the National Institute of Dental and Craniofacial Research is participating in PAR-19-193, " "Microbial-based Cancer Therapy-Bugs as Drugs (R01- Clinical Trial Not Allowed)".

The following changes have been made to reflect NIDCR's participation in this FOA:

Part 1. Overview Information

Components of Participating Organizations

National Cancer Institute (NCI)

National Institute on Dental and Craniofacial Research (NIDCR)

Catalog of Federal Domestic Assistance (CFDA) Numbers

93.396, 93.121

 

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description

The NIDCR is interested in all applications that are relevant to the NIDCR mission and strategic plan.

Potential applicants are encouraged to speak with a NIDCR program official to discuss the relevance of proposed research topic(s).

Section VII. Agency Contacts

The following contacts have been added:

Scientific/Research Contact(s)

Chiayeng Wang, Ph.D.
National Institute of Dental and Craniofacial Research (NIDCR)
Telephone: 301-827-4647
Email: chiayeng.wang@nih.gov

Financial/Grants Management Contact(s)

Diana Rutberg, M.B.A.
National Institute of Dental and Craniofacial Research (NIDCR)
Telephone: 301-594-4798
E-mail: rutbergd@mail.nih.gov

Inquiries

Please direct all inquiries to:

Chiayeng Wang, Ph.D.
National Institute of Dental and Craniofacial Research (NIDCR)
Telephone: 301-827-4647
Email: chiayeng.wang@nih.gov